For the in vivo analysis of pancreatic cancer development, the established KC model harboring mutated Kras which recapitulates PanIN progression, and the KPC model with mutated Kras and Trp53 frequently developing invasive PDAC are widely used.16 The gene discussed is KRAS; the disease is familial pancreatic carcinoma.